HT Partners’s AbbVie ABBV Stock Holding History

HT Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$690K	Hold	2,741	–	–	0.19%	32
2026 Q1	$596K	Hold	2,741	–	–	0.18%	33
2025 Q4	$626K	Hold	2,741	–	–	0.19%	32
2025 Q3	$635K	Hold	2,741	–	–	0.19%	32
2025 Q2	$509K	Hold	2,741	–	–	0.16%	32
2025 Q1	$574K	Hold	2,741	–	–	0.2%	30
2024 Q4	$487K	Hold	2,741	–	–	0.17%	31
2024 Q3	$541K	Hold	2,741	–	–	0.19%	29
2024 Q2	$470K	Hold	2,741	–	–	0.17%	30
2024 Q1	$499K	Sell	2,741 -135	-5%	-$23.3K	0.18%	29
2023 Q4	$446K	Hold	2,876	–	–	0.18%	28
2023 Q3	$429K	Hold	2,876	–	–	0.13%	30
2023 Q2	$387K	Sell	2,876 -60	-2%	-$8.8K	0.11%	34
2023 Q1	$468K	Buy	2,936 +195	+7%	+$29.8K	0.14%	30
2022 Q4	$443K	Hold	2,741	–	–	0.15%	26
2022 Q3	$368K	Hold	2,741	–	–	0.16%	29
2022 Q2	$420K	Hold	2,741	–	–	0.17%	30
2022 Q1	$444K	Hold	2,741	–	–	0.14%	31
2021 Q4	$371K	Hold	2,741	–	–	0.11%	36
2021 Q3	$296K	Hold	2,741	–	–	0.09%	39
2021 Q2	$309K	Hold	2,741	–	–	0.09%	36
2021 Q1	$297K	Hold	2,741	–	–	0.1%	37
2020 Q4	$294K	Buy	+2,741	New	+$263K	0.1%	36

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HT Partners's ABBV Position: Q2 2026 in Review

HT Partners held its AbbVie (ABBV) position steady in Q2 2026 at 2,741 shares worth $690K. The position accounts for 0.19% of the portfolio, ranked #32.

HT Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

HT Partners held 2,741 shares of AbbVie worth $690K as of Q2 2026.
HT Partners left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.19% of HT Partners's portfolio in Q2 2026, its #32 holding.
HT Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HT Partners's 13F filing for Q2 2026, filed 16 Jul 2026.